276 related articles for article (PubMed ID: 9760831)
1. [A feature of hematological findings in myelodysplastic syndromes].
Bando S; Niiya T; Murase M; Makino H
Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.
Buckstein R; Jang K; Friedlich J; Zhang L; Reis M; Chesney A; Wells RA
Leuk Res; 2009 Oct; 33(10):1313-8. PubMed ID: 19282029
[TBL] [Abstract][Full Text] [Related]
4. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
[TBL] [Abstract][Full Text] [Related]
6. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
7. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
8. [Histopathology and morphometry of hematopoiesis in bone marrow of AIDS patients in comparison with patients with myelodysplastic syndrome].
Kaloutsi V; Maschek H; Kohlmeyer U; Nafe R; Choritz H; Amor A; Georgii A
Verh Dtsch Ges Pathol; 1991; 75():131-5. PubMed ID: 1724815
[TBL] [Abstract][Full Text] [Related]
9. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
10. High incidence of apoptosis in peripheral blood of myelodysplastic syndrome patients determined by Papanicolaou-stained preparations.
Emura I
Lab Hematol; 2003; 9(1):42-6. PubMed ID: 12661827
[TBL] [Abstract][Full Text] [Related]
11. Refractory anemia and the myelodysplastic syndromes.
Lawrence LW
Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
[TBL] [Abstract][Full Text] [Related]
12. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
13. The significance of bone marrow cell morphology and its correlation with cytogenetic features in the diagnosis of MDS-RA patients.
Liu D; Chen Z; Xue Y; Lu D; Zhou Y; Gong J; Wu W; Liang J; Ma Q; Pan J; Wu Y; Wang Y; Zhang J; Shen J
Leuk Res; 2009 Aug; 33(8):1029-38. PubMed ID: 19411106
[TBL] [Abstract][Full Text] [Related]
14. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology].
Tomonaga M
Rinsho Byori; 2005 Jan; 53(1):54-60. PubMed ID: 15724491
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndrome in a patient with familial Pelger-Huet anomaly].
Hiraga H; Yabe H; Nagai K; Nakayama S
Rinsho Ketsueki; 1991 Nov; 32(11):1453-7. PubMed ID: 1758052
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
18. Dermatomyositis and myelodysplastic syndrome with myelofibrosis responding to methotrexate therapy.
Tsuji G; Maekawa S; Saigo K; Nobuhara Y; Nakamura T; Kawano S; Koshiba M; Asahara S; Chinzei T; Kumagai S
Am J Hematol; 2003 Nov; 74(3):175-8. PubMed ID: 14587044
[TBL] [Abstract][Full Text] [Related]
19. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
20. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
